These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8244820)

  • 1. The relationship between proliferative and oxygenation status in spontaneous canine tumors.
    Zeman EM; Calkins DP; Cline JM; Thrall DE; Raleigh JA
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):891-8. PubMed ID: 8244820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of the hypoxia marker CCI-103F in canine tumors.
    Cline JM; Thrall DE; Rosner GL; Raleigh JA
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):921-33. PubMed ID: 8138446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
    Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors.
    Raleigh JA; Zeman EM; Calkins DP; McEntee MC; Thrall DE
    Acta Oncol; 1995; 34(3):345-9. PubMed ID: 7779421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
    Cline JM; Rosner GL; Raleigh JA; Thrall DE
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):655-62. PubMed ID: 9112464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved system for quantifying AgNOR and PCNA in canine tumors.
    Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
    Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation.
    Thrall DE; McEntee MC; Cline JM; Raleigh JA
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):649-59. PubMed ID: 8113108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
    Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS
    Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of a spheroid model for the study of radiation and chemotherapy effects on hypoxic tumor cell populations.
    Moore DH; Rouse MB; Massenburg GS; Zeman EM
    Gynecol Oncol; 1992 Oct; 47(1):44-7. PubMed ID: 1427399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
    Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
    J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.
    Cline JM; Thrall DE; Page RL; Franko AJ; Raleigh JA
    Br J Cancer; 1990 Dec; 62(6):925-31. PubMed ID: 1701659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs.
    Gamblin RM; Sagartz JE; Couto CG
    Am J Vet Res; 1997 Aug; 58(8):857-63. PubMed ID: 9256970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
    Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
    Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of canine mast cell tumors: a comparison of three methods.
    Simoes JP; Schoning P; Butine M
    Vet Pathol; 1994 Nov; 31(6):637-47. PubMed ID: 7863578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ analysis of cellular proliferation in canine, feline and equine tumors by immunohistochemistry: a comparison of bromodeoxyuridine, proliferating cell nuclear antigen, and interchromatin-associated antigen immunostaining techniques.
    Théon AP; Metzger L; Griffey S
    J Vet Diagn Invest; 1994 Oct; 6(4):453-7. PubMed ID: 7858025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas.
    Nordsmark M; Høyer M; Keller J; Nielsen OS; Jensen OM; Overgaard J
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):701-8. PubMed ID: 8690636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression and microvascular density in soft tissue sarcomas in dogs.
    de Queiroz GF; Dagli ML; Fukumasu H; Zavala AA; Matera JM
    J Vet Diagn Invest; 2010 Jan; 22(1):105-8. PubMed ID: 20093695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.